OMCL Omnicell, Inc.

74.280.46 (+0.62%)
IEX real time price: 1:26:15 PM

Quote

Previous Close
-
Day Range
-
52 Week Range
$56.96-$92.59
Volume
89,000
Avg Volume
232,749
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$3.09B
Enterprise Value (EV)
$3.14B
PE Ratio
62.78
EV/EBITDA
31.55
Price/Sales
3.91
Price/Book
4.52
PEG Ratio
1.37

Financials

Revenue
$787.31M
Gross Profit
$372.33M
EBITDA
$99.64M
EPS, ttm
$1.18
Profit Margin
4.79%
Revenue/Employee
$317.46K
Next Earnings Date
10/24/2019 (9 days)
Debt to Equity
20%
Debt
$116.26M
Cash
$67.19M
Net Debt
$49.06M

Performance

Beta
1.08
200 Day Moving Avg
$76.17
50 Day Moving Avg
$72.01
52 Week Change
14.04%
YTD Change
23.76%
1 Month Change
1.95%
3 Month Change
-0.55%
6 Month Change
-8.82%
1 Year Change
14.04%
2 Year Change
45.60%
5 Year Change
168.14%

Share Count

Shares Outstanding
41.7M
Float
40.6M
Restricted Shares
1.0M
Restricted Shares, %
2.42%

Omnicell, Inc. Company Details

Sector: Technology Services

Industry: Information Technology Services

CEO: Randall A. Lipps

Website: http://www.omnicell.com

Description: Omnicell, Inc. engages in the provision of medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions. It operates through Automation & Analytics and Medication Adherence segments. The Automation & Analytics segment designs, manufactures, and sells medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment develops, manufactures and sells solutions to assist patients in becoming and remaining adherent to their medication regimens. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.

Employees: 2,480